Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31,249,203
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
2,464,649
-
Shares change
-
+613,873
-
Total reported value, excl. options
-
$11,852,572
-
Value change
-
+$2,944,615
-
Put/Call ratio
-
36%
-
Number of buys
-
22
-
Number of sells
-
-7
-
Price
-
$4.81
Significant Holders of Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) as of Q2 2022
47 filings reported holding ATNM - Actinium Pharmaceuticals, Inc. - Common Stock as of Q2 2022.
Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,464,649 shares
of 31,249,203 outstanding shares and own 7.9% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1,068,947 shares), BlackRock Inc. (231,816 shares), GEODE CAPITAL MANAGEMENT, LLC (172,217 shares), BLAIR WILLIAM & CO/IL (97,966 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (88,966 shares), STATE STREET CORP (75,215 shares), RENAISSANCE TECHNOLOGIES LLC (57,700 shares), TWO SIGMA INVESTMENTS, LP (57,218 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (55,965 shares), and CITADEL ADVISORS LLC (53,468 shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.